Complete Removal or Chemotherapy First: How Ovarian Cancer Surgery Is Decided, and When HIPEC Is Added

Ovarian cancer surgery has one goal: to leave no visible cancer behind. That result — written as R0 or CC-0 on the operation note — matters more to what follows than the size of the operation. So the real decision is not whether to operate, but when: now, if everything can be removed, or after three or four cycles of chemotherapy, if it cannot. Heated chemotherapy inside the abdomen (HIPEC) is added only in a specific setting.

Send the CT images, CA-125 and any biopsy or operation notes ahead of your appointment, so the consultation starts with them already read · +91-63590-11009

Dr Swati Shah, HIPEC and ovary cancer surgeon, Ahmedabad

Dr Swati Shah
MS, DrNB (Surgical Oncology)
HIPEC & Ovary Cancer Surgeon · Apollo Hospital, Bhat, Gandhinagar · Gota OPD, Ahmedabad

Indian Ovary Cancer Institute (IOCI), Shah’s Gastro, Cancer & Robotic Surgery Centre — an institute that works on one organ, the ovary. Trained at high-volume cancer centres, fully qualified in surgical oncology, and 18 years of experience in cancer surgery for women. Rated 5.0 from 18 Google reviews at the IOCI clinic and 4.95 from 56 at Apollo, Bhat.

What "complete" means: R0 and CC-0

R0 means no visible residual disease at the end of the operation. CC-0, the completeness-of-cytoreduction score used in peritoneal surgery, means no visible nodule left anywhere. Both describe the same target, and it is the target of every ovarian cancer operation done at the Indian Ovary Cancer Institute.

For many years “optimal debulking” meant leaving nothing larger than a centimetre. That standard has been replaced. The difference between leaving nothing visible and leaving even small nodules is large and consistent across the evidence, so “optimal” is no longer the aim. The aim is always none.

The reason lies in how this cancer behaves. Ovarian, tubal and peritoneal cancer spreads across the surface of the abdomen — the omentum, the undersurface of the diaphragm, the coverings of the bowel — and it usually responds well to platinum chemotherapy. Surgery’s job is to remove everything that can be seen, so that the chemotherapy only has to deal with what cannot be seen.

Judging whether everything can be removed — before the abdomen is opened

Resectability is judged from a contrast CT of the chest, abdomen and pelvis, and, where the CT leaves doubt, a diagnostic laparoscopy scored with the Fagotti index. It is never decided on imaging alone when a laparoscopy would settle it.

On the CT, five findings decide most cases:

  • Omental cake — the fatty apron thickened by tumour. Usually removable.
  • Disease on the diaphragm and around the liver’s entrance (porta hepatis) — removable, but only by a team experienced in upper-abdominal surgery.
  • Retraction of the small-bowel mesentery root — often the finding that makes complete removal unrealistic at the first operation.
  • Bowel involvement — decides whether a bowel resection, and possibly a stoma, will be needed.
  • Retroperitoneal lymph nodes — bulky nodes are removed; normal-looking nodes in advanced disease are not stripped routinely.

Blood markers matter too. If the balance between CA-125 and CEA does not point to the ovary, a colonoscopy and upper GI endoscopy are done first, so that a bowel cancer is not operated on as an ovarian one. Tissue is confirmed before any chemotherapy, by an image-guided core biopsy or at laparoscopy.

Surgery first or chemotherapy first

Primary surgery is chosen when complete removal is achievable and the patient is fit. Chemotherapy first, followed by interval surgery, is chosen when the disease cannot yet be removed completely, or when fitness, nutrition or other illness would make a long operation unsafe. Both are standard; the tumour board makes the choice.

 Primary cytoreduction (surgery first)Chemotherapy first, then interval cytoreduction
Chosen whenComplete removal looks achievable and you are fitDisease at the mesentery root, porta hepatis or in large volume in the upper abdomen; or poor fitness, low albumin, or other illness
SequenceOperation, then six cycles of chemotherapyThree or four cycles, the operation, then the remaining cycles to complete six
HIPECNot established at a first operation — investigational onlySupported by trial evidence when the interval operation is complete
GoalNo visible diseaseNo visible disease

A complete operation after chemotherapy is better than an incomplete operation at the start. Matching the timing to the disease, so that the result is complete, is the whole of the decision.

The rule: complete, or stop and treat first

An intentionally incomplete operation is never done. If, once the abdomen is open, complete removal proves impossible, tissue is taken, the abdomen is closed, and chemotherapy is given first, with a planned operation to follow.

Families sometimes hear this as “they opened and closed”. It is the opposite of giving up. A long, high-risk operation that leaves disease behind exposes a woman to all of the complications and almost none of the benefit. Stopping, treating, and returning for a complete operation protects both her safety and her chance of a good result. This possibility is explained at the consent discussion, so it is never a surprise.

What a complete cytoreduction may include

The operation is tailored to where the disease is. Its fixed core is removal of the uterus, both tubes and ovaries and the omentum; everything else is done only when it is needed to leave nothing visible.

  • The core: hysterectomy, removal of both tubes and ovaries, and removal of the omentum below — and where involved, above — the transverse colon. Peritoneal washings are taken first; in apparent early disease, systematic peritoneal biopsies are added.
  • The upper abdomen: stripping or full-thickness resection of the diaphragm, removal of the spleen, the tail of the pancreas or the gallbladder, and clearance around the porta hepatis — only where disease sits there.
  • The bowel: a segment is removed when that converts an incomplete operation into a complete one. A stoma may be needed, so consent for it is taken before surgery, every time.
  • The appendix: removed for mucinous tumours.
  • Lymph nodes: a full pelvic and para-aortic dissection is part of staging in apparent early disease. In advanced disease with normal-looking nodes after a complete operation, routine dissection adds complications without improving survival, so only bulky nodes are removed.

Drains are placed after bowel resection, diaphragm surgery or HIPEC, and not routinely otherwise. A nasogastric tube is not kept routinely.

HIPEC: where the evidence is, and where it is not

HIPEC — cisplatin, heated and circulated through the abdomen for ninety minutes at the end of surgery — has trial evidence of a real survival gain at interval cytoreduction after chemotherapy in advanced disease. At a primary operation it is still investigational. It is never added when cytoreduction is incomplete.

Three conditions decide whether HIPEC is offered:

  1. The setting. Interval surgery after neoadjuvant chemotherapy, in advanced disease that has spread through the abdomen. That is the setting the evidence supports.
  2. Completeness. Heated chemotherapy acts on the surface layer of tissue only, so it can deal with what cannot be seen but not with nodules that were left. If cytoreduction is incomplete, HIPEC adds risk without benefit and is not given.
  3. Your kidneys and blood counts. Cisplatin can affect the kidneys and lower blood counts, so kidney function and fluid balance are planned with the anaesthesia team in advance.

At a first, primary operation, HIPEC is not yet established; the trial addressing that question had not reported when this pathway was last reviewed. If it is discussed in that setting, it is presented to you as investigational.

The heated-perfusion machine is available at Apollo Hospital, Bhat, and is booked, with its team on standby, at the time the operation is listed — so HIPEC is offered here whenever the evidence supports it, rather than when equipment happens to be free.

Why depth in this one operation matters

Whether an operation ends complete depends less on intent than on whether the team can deal with disease on the diaphragm, around the liver and on the bowel in the same sitting. That capability comes from doing this one operation repeatedly, as a team, which is why surgery for advanced ovarian cancer belongs in units that concentrate it.

An operation that stops short because no one present can safely resect the diaphragm or a segment of bowel has failed at its central purpose. At the Indian Ovary Cancer Institute, the ovary is the whole of the work. A GI surgeon joins the operation whenever the bowel or the upper abdomen is involved, so completeness never depends on one person’s range. Anaesthesia and intensive care are planned for a long operation with large fluid shifts, and for the particular kidney care that cisplatin HIPEC needs.

Volume here is not a number to advertise. It is the reason the tumour board can say “complete removal is achievable” with confidence — and the reason it can say “not yet, chemotherapy first” without that meaning surrender.

Preparing your body for a long operation

Preparation starts at the OPD visit, not the night before:

  • A walking programme, breathing exercises with an incentive spirometer, and protein supplements from the first visit. A dietitian joins if you have lost weight, your albumin is low, or you are eating poorly.
  • Haemoglobin brought above ten and albumin rising before major cytoreduction; iron deficiency corrected.
  • A carbohydrate drink the evening before and two to three hours before anaesthesia, unless the bowel is obstructed. Bowel preparation only when a colorectal resection is planned.
  • The stoma site marked by the stoma nurse whenever a bowel resection is possible.
  • A clot-risk assessment, and blood-thinning injections continued for four weeks after discharge, because ovarian cancer carries the highest clot risk of the gynaecological cancers.

Complications, and the certainties

Complications of cytoreductive surgery are named here in words; your own figures, which depend on your age, fitness, albumin and the extent of the operation, are given at the consent discussion.

They include bleeding needing transfusion, wound infection, clots in the leg or lung, a need for intensive care, a bowel resection becoming necessary, a stoma, a leak where bowel is joined, injury to the bladder or ureter, fluid around the lung after diaphragm surgery, a pancreatic leak after removal of the spleen or the tail of the pancreas, a slow return of bowel function, lymph collection or leg swelling after node removal, a return to theatre, and a risk to life that is higher when extensive upper-abdominal surgery is combined with HIPEC. HIPEC adds a risk of kidney injury and low blood counts.

Four things are certainties, not risks: if both ovaries are removed, menopause is immediate and permanent; fertility ends unless a fertility-sparing operation was specifically planned; chemotherapy follows surgery; and follow-up is lifelong. Dr Swati Shah discusses each of them with you personally before the operation.

What patients and families say

★★★★★

“My relative had advanced ovarian cancer involving the omentum and peritoneal deposits. We consulted Indian Ovarian Cancer Institute (IOCI) because of its expertise in complex ovarian cancer surgery. The doctors explained the importance of achieving complete tumour removal, and Cytoreductive Surgery (CRS) was performed successfully. We are thankful for the excellent treatment and compassionate care provided throughout the journey.”

Sharukh Bhadula, August 2026

★★★★★

“We are extremely grateful to Dr. Swati Shah for performing CRS HIPEC surgery. From the first consultation, she explained everything clearly and gave us confidence throughout the treatment journey. Her expertise, dedication, and compassionate approach made us feel comfortable and supported at every step. The surgery and post-operative care were handled very professionally, and we are very thankful for the care and guidance provided. Dr. Swati Shah is an excellent cancer surgeon, and we highly recommend her to anyone looking for expert care and treatment.”

Vaibhav Parmar, September 2026

★★★★★

“HIPEC technology very well explained,and accordingly treated my spouse,kudos, her recovery went well till now”

Deepak Goswami, August 2026

A patient of Dr Swati Shah’s describes her cytoreductive surgery for ovarian cancer (in Hindi).

Your journey with us

  1. Book your consultation. The IOCI clinic at Gota, Ahmedabad. Bring the CT images themselves, the CA-125 and other markers, and any biopsy or previous operation notes.
  2. Tests and a written plan. Resectability judged on CT and, if needed, laparoscopy; the BRCA and HRD test sent; the tumour board decides between surgery first and chemotherapy first, and whether HIPEC applies.
  3. The surgery. Complete cytoreduction at Apollo Hospital, Bhat — at the start, or after three or four cycles of chemotherapy — with HIPEC when the setting supports it.
  4. A short hospital stay. Sitting out of bed the same day, walking from the next, home usually within about a week once you are eating and comfortable.
  5. Follow-up and full healing. Histology reviewed and medical oncology booked before discharge; the remaining chemotherapy and maintenance; review every three months for the first two years.

Cost, insurance and admission

What moves the estimate is the extent of the cytoreduction, whether HIPEC is added, whether a bowel resection or stoma is needed, and the days spent in intensive care and in hospital. Cashless pre-authorisation is arranged through the Apollo Hospital, Bhat, insurance desk where your policy allows it.

Plan also for the chemotherapy before or after surgery, the gene test sent at diagnosis, and maintenance medicine, which can be the largest single cost and is discussed at the first counselling rather than at the prescription.

Frequently asked questions

What does CC-0 mean on my operation note?

It means no visible cancer was left anywhere in the abdomen at the end of the operation. CC-0 is the completeness-of-cytoreduction score used in peritoneal surgery; R0 says the same thing. It is the single result of the operation that most influences what happens afterwards.

My doctor advised chemotherapy before the operation. Is the surgery being avoided?

No. When the CT or a diagnostic laparoscopy shows that not every deposit could be removed today, or when you are too unwell or undernourished for a long operation, three or four cycles of chemotherapy are given first. The aim is to make complete removal possible at the interval operation, which then follows. The total course of chemotherapy is still six cycles.

Is HIPEC given to every woman with ovarian cancer?

No. The evidence supports HIPEC at the interval operation after chemotherapy, in advanced disease, when every visible deposit has been removed. HIPEC at a first, primary operation is still investigational, and it is never added when cytoreduction is incomplete.

What happens if the surgeon finds that not everything can be removed?

The operation is not continued as a partial debulking. Tissue is taken, the abdomen is closed, and chemotherapy is given first, with a planned operation later. You are told about this possibility at the consent discussion, before surgery.

Will I need a bag (stoma)?

Sometimes. If removing a segment of bowel is what makes the operation complete, the bowel is removed, and occasionally a temporary or permanent stoma is needed. Consent for bowel resection and stoma is always taken before the operation, and the stoma nurse marks the site in advance.

Are the lymph nodes removed in advanced ovarian cancer?

Only if they are enlarged. In advanced disease, when the nodes look normal and every visible deposit has been removed, routine removal of all the pelvic and para-aortic nodes adds complications without helping survival. In apparent early-stage disease, the nodes are removed as part of staging.

Where Dr Swati Shah sees and operates

IOCI clinic, Gota, Ahmedabad

Indian Ovary Cancer Institute I Ovary cyst & tumour treatment
SF-203, 2nd Floor, Olive Greens, Gota, S G Highway, Ahmedabad, Gujarat 382481

+91-63590-11009 · Open in Google Maps

Apollo Hospital, Bhat

Dr Swati Shah Gynec Oncologist I Uterus, Cervix, Ovary Cancer I Robotic & CRS HIPEC
Apollo Hospital International Limited, Plot No. 1 A, GIDC Bhat Industrial Estate, Bhat, Gandhinagar, Gujarat 382428

+91-63590-11009 · Open in Google Maps

Consultation at the IOCI clinic, Gota, Ahmedabad. Surgery at Apollo Hospital, Bhat, Gandhinagar.

Related on this site

Get health updates from Dr Swati Shah on WhatsApp

Swasth Parivar: twice a month, practical advice on recovery, diet and warning signs. No advertising. Stop any time.

Your number is used for these updates and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.

Make An Appointment!